CEA 605-613 (HLA-A*02:01) YLSGANLNL
€105.00*
Description
CAP1 peptide YLSGANLNL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Adenylyl Cyclase-Associated Protein 1 (CAP1) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.
TechData
| Sequence: | YLSGANLNL |
| Gene: | CEACAM5 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Carcinoembryonic antigen-related cell adhesion molecule 5 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |
More CEA peptides
